Page last updated: 2024-09-03

imatinib mesylate and Leukemia, Hairy Cell

imatinib mesylate has been researched along with Leukemia, Hairy Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azzara', A; Carulli, G; Fazzi, R; Galimberti, S; Orciuolo, E; Petrini, M; Testi, C	1

Other Studies

1 other study(ies) available for imatinib mesylate and Leukemia, Hairy Cell

Article	Year
Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy. Leukemia research, 2006, Volume: 30, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Imatinib Mesylate; Interferons; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Rituximab; Treatment Outcome	2006

Article

Year

Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.

Leukemia research, 2006, Volume: 30, Issue:3

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Imatinib Mesylate; Interferons; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Rituximab; Treatment Outcome

2006